ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy (2010)
Willrich, Maria Alice Vieira; Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Arazi, Simone Sorkin; Oliveira, Raquel de; Maureira, Alvaro Danilo Cerda; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidades: HU, FCF
Subjects: HIPERCOLESTEROLEMIA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira et al. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Hospital Universitário, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2010
APA
Willrich, M. A. V., Genvigir, F. D. V., Rodrigues, A. C., Arazi, S. S., Oliveira, R. de, Maureira, A. D. C., et al. (2010). CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Hospital Universitário, Universidade de São Paulo.
NLM
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R de, Maureira ADC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 44 res. FCF084.[citado 2024 nov. 02 ]
Vancouver
Willrich MAV, Genvigir FDV, Rodrigues AC, Arazi SS, Oliveira R de, Maureira ADC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 44 res. FCF084.[citado 2024 nov. 02 ]
Artigo de periodico
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells (2010)
Genvigir, Fabiana Dalla Vecchia; Rodrigues, Alice Cristina ; Cerda, Alvaro; Arazi, Simone Sorkin; Willrich, Maria Alice Vieira; Oliveira, Raquel; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Curi, Rui; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidades: FCF, HU, ICB
Subjects: EXPRESSÃO GÊNICA, COLESTEROL, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. Pharmacogenomics, v. 11, n. 9, p. 1235-1246, 2010Tradução . . Disponível em: https://doi.org/10.2217/pgs.10.93. Acesso em: 02 nov. 2024.
APA
Genvigir, F. D. V., Rodrigues, A. C., Cerda, A., Arazi, S. S., Willrich, M. A. V., Oliveira, R., et al. (2010). Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. Pharmacogenomics, 11( 9), 1235-1246. doi:10.2217/pgs.10.93
NLM
Genvigir FDV, Rodrigues AC, Cerda A, Arazi SS, Willrich MAV, Oliveira R, Hirata MH, Dórea EL, Bernik MMS, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells [Internet]. Pharmacogenomics. 2010 ; 11( 9): 1235-1246.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2217/pgs.10.93
Vancouver
Genvigir FDV, Rodrigues AC, Cerda A, Arazi SS, Willrich MAV, Oliveira R, Hirata MH, Dórea EL, Bernik MMS, Curi R, Hirata RDC. Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells [Internet]. Pharmacogenomics. 2010 ; 11( 9): 1235-1246.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2217/pgs.10.93
Trabalho de evento-resumo periodico
The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response (2010)
Rodrigues, Alice Cristina ; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Hirata, Mario Hiroyuki ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidades: FCF, HU
Subjects: POLIMORFISMO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2010
APA
Rodrigues, A. C., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Hirata, M. H., Dórea, E. L., et al. (2010). The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Rodrigues AC, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 77 res. FCF149.[citado 2024 nov. 02 ]
Vancouver
Rodrigues AC, Genvigir FDV, Willrich MAV, Arazi SS, Hirata MH, Dórea EL, Bernik MMS, Hirata RDC. The contribution of genetic polymorphisms in 60 candidate genes to variability in atorvastatin response. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 77 res. FCF149.[citado 2024 nov. 02 ]

USP Schools

ReP

Filtros

Authors

Subjects